Anti-LZTFL1 monoclonal antibody

Pre-made anti-LZTFL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LZTFL1/LZTFL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1132-Ab-1/ GM-Tg-hg-IP1132-Ab-2Anti-Human LZTFL1 monoclonal antibodyHuman
GM-Tg-rg-IP1132-Ab-1/ GM-Tg-rg-IP1132-Ab-2Anti-Rat LZTFL1 monoclonal antibodyRat
GM-Tg-mg-IP1132-Ab-1/ GM-Tg-mg-IP1132-Ab-2Anti-Mouse LZTFL1 monoclonal antibodyMouse
GM-Tg-cynog-IP1132-Ab-1/ GM-Tg-cynog-IP1132-Ab-2Anti-Cynomolgus/ Rhesus macaque LZTFL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1132-Ab-1/ GM-Tg-felg-IP1132-Ab-2Anti-Feline LZTFL1 monoclonal antibodyFeline
GM-Tg-cang-IP1132-Ab-1/ GM-Tg-cang-IP1132-Ab-2Anti-Canine LZTFL1 monoclonal antibodyCanine
GM-Tg-bovg-IP1132-Ab-1/ GM-Tg-bovg-IP1132-Ab-2Anti-Bovine LZTFL1 monoclonal antibodyBovine
GM-Tg-equg-IP1132-Ab-1/ GM-Tg-equg-IP1132-Ab-2Anti-Equine LZTFL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1132-Ab-1/ GM-Tg-hg-IP1132-Ab-2; GM-Tg-rg-IP1132-Ab-1/ GM-Tg-rg-IP1132-Ab-2;
GM-Tg-mg-IP1132-Ab-1/ GM-Tg-mg-IP1132-Ab-2; GM-Tg-cynog-IP1132-Ab-1/ GM-Tg-cynog-IP1132-Ab-2;
GM-Tg-felg-IP1132-Ab-1/ GM-Tg-felg-IP1132-Ab-2; GM-Tg-cang-IP1132-Ab-1/ GM-Tg-cang-IP1132-Ab-2;
GM-Tg-bovg-IP1132-Ab-1/ GM-Tg-bovg-IP1132-Ab-2; GM-Tg-equg-IP1132-Ab-1/ GM-Tg-equg-IP1132-Ab-2
Products NameAnti-LZTFL1 monoclonal antibody
Formatmab
Target NameLZTFL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LZTFL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1132-Ag-1Recombinant multi-species LZTL1/ LZTFL1/ BBS17 protein
    ORF Viral VectorvGMLP004994human LZTFL1 Lentivirus particle
    ORF Viral VectorpGMLP004994human LZTFL1 Lentivirus plasmid
    ORF Viral VectorpGMLPm003939mouse Lztfl1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003939mouse Lztfl1 Lentivirus particle


    Target information

    Target IDGM-IP1132
    Target NameLZTFL1
    Gene ID54585,93730,316102,714191,476651,101082984,512570,100054515
    Gene Symbol and Synonyms5530402H04Rik,6130400H19Rik,BBS17,LZTFL1
    Uniprot AccessionQ9NQ48,Q562C6,Q3ZBL4
    Uniprot Entry NameLZTL1_HUMAN,LZTL1_RAT,LZTL1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000163818
    Target ClassificationN/A

    The target: LZTFL1, gene name: LZTFL1, also named as BBS17. This gene encodes a ubiquitously expressed protein that localizes to the cytoplasm. This protein interacts with Bardet-Biedl Syndrome (BBS) proteins and, through its interaction with BBS protein complexes, regulates protein trafficking to the ciliary membrane. Nonsense mutations in this gene cause a form of Bardet-Biedl Syndrome; a ciliopathy characterized in part by polydactyly, obesity, cognitive impairment, hypogonadism, and kidney failure. This gene may also function as a tumor suppressor; possibly by interacting with E-cadherin and the actin cytoskeleton and thereby regulating the transition of epithelial cells to mesenchymal cells. [provided by RefSeq, Aug 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.